STUDY

Efudex cream worked best for pre-cancer sun spots on the head

“Randomized Trial of Four Treatment Approaches for Actinic Keratosis.” Jansen MHE et al. The New England Journal of Medicine. March 2019

Jansen MHE et al. · The New England Journal of Medicine · March 2019

Randomized controlled trial
The finding

For multiple actinic keratoses on the head, 5% fluorouracil cream had the highest estimated success at 12 months among the four field treatments tested.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized and single-blind. Participants were assigned to four different treatment regimens at four hospitals in the Netherlands.
At a glance

Who was studied and for how long

Randomized
624 adults
602 in the main analysis
Follow-up
12 months
After the end of treatment
Condition
Actinic keratoses
At least five spots in one area on the head
Compared
Four field treatments
Creams, gel or light therapy
What they did

How the study worked

624 adultsactinic keratosesRANDOMSPLITFluorouracil155 assigned · 5% creamImiquimod156 assigned · 5% creamMAL-PDT156 assigned · light therapyIngenol mebutate157 assigned · 0.015% gelMEASURED AT12 monthsafter treatment624 adultsactinic keratosesRANDOMSPLITFluorouracil155 assigned · 5% creamImiquimod156 assigned · 5% creamMAL-PDT156 assigned · light therapyIngenol mebutate157 assigned · 0.015% gelMEASURED AT12 monthsafter treatment
Random assignmentThe study split 624 adults among four active treatment groups.
Treat the whole areaParticipants received 5% fluorouracil, 5% imiquimod, methyl aminolevulinate photodynamic therapy, or 0.015% ingenol mebutate.
Count remaining spotsSuccess meant at least a 75% reduction in lesion count without treatment failure by 12 months.
What they found

The results

FluorouracilImiquimodMAL-PDT

Estimated success at 12 months

Estimated chance of remaining free from treatment failure one year after treatment.

Fluorouracil
74.7%
Imiquimod
53.9%
MAL-PDT
37.7%
Ingenol mebutate
28.9%
Each comparison with fluorouracil: p ≤ 0.001
Fluorouracil led on sustained lesion reduction. The percentages are estimates that account for follow-up time. They do not show how many people became completely clear or whether a treatment prevented skin cancer.
Who paid for it

Funding and conflicts of interest

The Netherlands Organization for Health Research and Development funded the study.

How much to trust it

Strengths and limits

Strengths

  • Large trial across four hospitals
  • Compared four active options directly
  • Followed patients for one year after treatment

Limits

  • Studied multiple lesions on the head only
  • Tested specific treatment regimens; results do not compare other light therapy protocols
  • 22 randomized participants were excluded from the main analysis
  • The main outcome was lesion reduction, not cancer prevention
High confidence in this comparison. This was a large randomized trial with a year of follow-up in a defined treatment area.
What it means for you

The takeaway

Fluorouracil led at one year

Of the four tested regimens, 5% fluorouracil cream gave the most durable reduction in spots on the head.

This study does not establish how the treatments compare at other body sites.

Terms in this study

Words worth knowing

Actinic keratoses

Rough, scaly spots linked to long-term sun damage.

Field treatment

Treatment of a whole area of affected skin rather than each spot on its own.

MAL-PDT

Photodynamic therapy using methyl aminolevulinate, a cream that makes treated cells sensitive to light.

Original source

Jansen MHE, Kessels JPHM, Nelemans PJ, Kouloubis N, Arits AHMM, van Pelt HPA, Quaedvlieg PJF, Essers BAB, Steijlen PM, Kelleners-Smeets NWJ, Mosterd K. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.. N Engl J Med. 2019;380(10):935-946.

PMID 30855743